{
  "created_at": "Fri Oct 01 11:0:37 +0000 2021",
  "id": 1443883577490411500,
  "id_str": "1443883577490411527",
  "full_text": "The drug maker Merck will seek authorization for the first antiviral pill for Covid. The drug, molnupiravir, cut the risk of hospitalization or death in half when given to high-risk people early in their infections, a clinical trial found.\nhttps://t.co/6VyYq3iDtJ",
  "truncated": false,
  "display_text_range": [
    0,
    263
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/6VyYq3iDtJ",
        "expanded_url": "https://nyti.ms/3m8rDqM",
        "display_url": "nyti.ms/3m8rDqM",
        "indices": [
          240,
          263
        ]
      }
    ]
  },
  "source": "<a href=\"http://www.socialflow.com\" rel=\"nofollow\">SocialFlow</a>",
  "in_reply_to_status_id": null,
  "in_reply_to_status_id_str": null,
  "in_reply_to_user_id": null,
  "in_reply_to_user_id_str": null,
  "in_reply_to_screen_name": null,
  "user": {
    "id": 807095,
    "id_str": "807095",
    "name": "The New York Times",
    "screen_name": "nytimes",
    "location": "New York City",
    "description": "News tips? Share them here: https://t.co/ghL9OoYKMM",
    "url": "http://t.co/ahvuWqicF9",
    "entities": {
      "url": {
        "urls": [
          {
            "url": "http://t.co/ahvuWqicF9",
            "expanded_url": "http://www.nytimes.com/",
            "display_url": "nytimes.com",
            "indices": [
              0,
              22
            ]
          }
        ]
      },
      "description": {
        "urls": [
          {
            "url": "https://t.co/ghL9OoYKMM",
            "expanded_url": "http://nyti.ms/2FVHq9v",
            "display_url": "nyti.ms/2FVHq9v",
            "indices": [
              28,
              51
            ]
          }
        ]
      }
    },
    "protected": false,
    "followers_count": 50600812,
    "friends_count": 852,
    "listed_count": 211208,
    "created_at": "Fri Mar 02 20:41:42 +0000 2007",
    "favourites_count": 18561,
    "utc_offset": null,
    "time_zone": null,
    "geo_enabled": false,
    "verified": true,
    "statuses_count": 448518,
    "lang": null,
    "contributors_enabled": false,
    "is_translator": false,
    "is_translation_enabled": true,
    "profile_background_color": "131516",
    "profile_background_image_url": "http://abs.twimg.com/images/themes/theme14/bg.gif",
    "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme14/bg.gif",
    "profile_background_tile": true,
    "profile_image_url": "http://pbs.twimg.com/profile_images/1098244578472280064/gjkVMelR_normal.png",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/1098244578472280064/gjkVMelR_normal.png",
    "profile_banner_url": "https://pbs.twimg.com/profile_banners/807095/1584666392",
    "profile_link_color": "607696",
    "profile_sidebar_border_color": "FFFFFF",
    "profile_sidebar_fill_color": "EFEFEF",
    "profile_text_color": "333333",
    "profile_use_background_image": true,
    "has_extended_profile": false,
    "default_profile": false,
    "default_profile_image": false,
    "following": true,
    "follow_request_sent": false,
    "notifications": false,
    "translator_type": "none",
    "withheld_in_countries": []
  },
  "geo": null,
  "coordinates": null,
  "place": null,
  "contributors": null,
  "is_quote_status": false,
  "retweet_count": 220,
  "favorite_count": 589,
  "favorited": false,
  "retweeted": false,
  "possibly_sensitive": false,
  "lang": "en",
  "original_created_at": "Fri Oct 01 10:20:45 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "製薬メーカーのメルク社は、「コビット」の初の抗ウイルス剤の認可を求めます。この薬、モルヌピラビルは、ハイリスクの人に感染初期に投与すると、入院や死亡のリスクが半分になることが臨床試験で明らかになった。\nhttps://t.co/6VyYq3iDtJ"
    },
    {
      "locale": "zh",
      "full_text": "制药商默克公司将为科威德的第一种抗病毒药寻求授权。一项临床试验发现，这种药物--莫努匹拉韦，在感染早期给高危人群服用时，可将住院或死亡的风险减半。\nhttps://t.co/6VyYq3iDtJ"
    },
    {
      "locale": "zh-Hant",
      "full_text": "製藥商默克公司將爲科威德的第一種抗病毒藥尋求授權。一項臨牀試驗發現，這種藥物--莫努匹拉韋，在感染早期給高危人羣服用時，可將住院或死亡的風險減半。\nhttps://t.co/6VyYq3iDtJ"
    }
  ]
}